From: A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study
Total
108% ± 93%
SI
> 31
106% ± 60%
21 < SI < 30
78% ± 35%
< 20
75% ± 36%